Cargando…
Efficacy and safety of HDACIs in the treatment of metastatic or unresectable renal cell carcinoma with a clear cell phenotype: A systematic review and meta-analysis
BACKGROUND: In this study, we evaluated the efficacy and safety of histone deacetylase inhibitors (HDACIs) in the treatment of renal cell carcinoma (RCC). METHODS: PubMed, EMBASE, the Cochrane Library, CNKI, and the Wanfang database were searched to retrieve studies describing the use of HDACIs for...
Autores principales: | Chen, Juan, Ren, Jia-Ju, Cai, Jiangxia, Wang, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341361/ https://www.ncbi.nlm.nih.gov/pubmed/34397830 http://dx.doi.org/10.1097/MD.0000000000026788 |
Ejemplares similares
-
Novel survival nomograms for patients with lung metastatic clear cell renal cell carcinoma: A population-based study
por: Zhang, Lei, et al.
Publicado: (2020) -
Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes: A case report
por: Zheng, Guoyang, et al.
Publicado: (2017) -
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021) -
Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
por: Fu, Hangcheng, et al.
Publicado: (2016) -
The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma
por: Xu, Weiqiang, et al.
Publicado: (2020)